Science 37
Founded 2014 · 293 employees on LinkedIn · 4 known investors
Find your way into Science 37
286 people in our graph share verified history with the Science 37 team — schools, employers, funds. One of them is your warm intro.
Science37 operates a decentralized clinical trial platform supported by a network of medical directors across specialties including cardiology, neurology, psychiatry, pediatrics, and internal medicine. The company serves the clinical research and pharmaceutical industry.
Founders & leadership
Investors · 4
Funding
SEC filings, press & company announcements$40M disclosed across 1 round · 2020
- $40MraisedAug 2020 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Science 37 went on to found or lead other companies.
Competitors · 2
by search overlap
Companies competing with Science 37 for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Science 37 do?
- Science37 operates a decentralized clinical trial platform supported by a network of medical directors across specialties including cardiology, neurology, psychiatry, pediatrics, and internal medicine. The company serves the clinical research and pharmaceutical industry.
- Who are Science 37's investors?
- Science 37's investors include Glynn Capital Management, Lux Capital, Sanofi Ventures, Inertia Ventures.
- How much funding has Science 37 raised?
- Science 37 has disclosed $40M raised across 1 round.